Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia
- 1 July 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (13) , 1989-1993
- https://doi.org/10.1016/0006-2952(83)90416-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemiaThe American Journal of Medicine, 1981
- The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMPProstaglandins and Medicine, 1980
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroNew England Journal of Medicine, 1980
- Selective Binding Site for [3H]Prostacyclin on PlateletsJournal of Clinical Investigation, 1979
- PLATELET THROMBOXANES AND SERUM-CHOLESTEROLThe Lancet, 1979
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Platelet hypersensitivity induced by cholesterol incorporation.Journal of Clinical Investigation, 1975
- Platelet Function in HyperlipoproteinemiaNew England Journal of Medicine, 1974
- PLATELET FUNCTION AND PLATELET PHOSPHOLIPIDS IN PATIENTS WITH HYPERBETALIPOPROTEINEMIAActa Medica Scandinavica, 1971
- Enhancement of platelet aggregation and adhesiveness by β-lipoproteinJournal of Atherosclerosis Research, 1968